National Institute for Health and Clinical Excellence (NICE)
NICE issues standard on improving maternal and child nutrition
A quality standard to help improve maternal and child nutrition was published yesterday by the National Institute for Health and Care Excellence.
A healthy diet is important for women who may become pregnant, as the woman's nutrition influences how her baby grows and develops and lays the foundations for her child's health. The mother's own health also depends on how well-nourished she is before, during and after pregnancy.
During the early years of a child's life, their diet has an effect on their growth and development. Diet is linked to many common childhood conditions such as iron-deficiency anaemia, tooth decay and vitamin D deficiency. It can also affect the risk of developing conditions such as coronary heart disease, diabetes and obesity in adult life.
The new standard aims to support improved nutrition for women who may become pregnant before, during and after pregnancy (up to a year after birth), and for babies and pre-school children. With a focus on low-income and other disadvantaged households, the standard is expected to contribute to improving outcomes in areas including postnatal depression, childhood illnesses and infections and iron-deficiency anaemia.
Professor Gill Leng, Deputy Chief Executive of NICE, said: “Good nutrition before, during and after pregnancy benefits the growth and development of the baby and the health of the mother. Women who may become pregnant need to be aware of the importance of a healthy diet as there’s most benefit from good nutrition before conception and in the first 12 weeks of pregnancy. There’s a strong link between poor maternal and child nutrition and deprivation, so improving the nutritional status of mothers and pre-school children who are disadvantaged is vital.
"The quality statements set out the priority actions to enable better nutrition for women who become pregnant and their children – such as advice on eating healthily during pregnancy, and support for breastfeeding. Making sure that these priority steps are put into practice will help to improve the health of mothers-to-be and give their babies the best start in life.”
The quality statements include:
- Pregnant women attending antenatal and health visitor appointments are advised how to eat healthily in pregnancy
- Women with a BMI of 30 or more following childbirth are offered a structured weight-loss programme
- Pregnant women and parents and carers of children under 4 years who may be eligible for the Healthy Start scheme are given information and support to apply
- Women receive breastfeeding support from a service that uses an evaluated, structured programme.
NICE has also issued a separate quality standard to help improve the care of people with drug allergies and ensure they are spared from serious harm. The quality standard includes 6 statements with priorities for healthcare professionals on how best to document allergies and how this information should be shared across NHS services as well as with patients themselves.
For more information call the NICE press office on 0300 323 0142, or out of hours on 07775 583 813.
Notes to Editors
About the NICE quality standard
- The standard, ‘Nutrition: Improving maternal and child nutrition’ is available at: http://www.nice.org.uk/guidance/qs98.
- The standard, ‘Drug allergy: diagnosis and management’ is available at: http://www.nice.org.uk/guidance/qs97.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for driving improvement and excellence in the health and social care system. We develop guidance, standards and information on high-quality health and social care. We also advise on ways to promote healthy living and prevent ill health.
Our aim is to help practitioners deliver the best possible care and give people the most effective treatments, which are based on the most up-to-date evidence and provide value for money, in order to reduce inequalities and variation.
Our products and resources are produced for the NHS, local authorities, care providers, charities, and anyone who has a responsibility for commissioning or providing healthcare, public health or social care services.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
NICE and PHE recommend all employers give mental health training for managers17/09/2021 11:10:00
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
NICE recommends treatment for people with juvenile idiopathic arthritis10/09/2021 11:15:00
NICE yesterday (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.
Professor Gillian Leng to retire from NICE09/09/2021 14:15:00
Professor Leng has spent more than 20 years working at NICE.
NICE draft guidance recommends apalutamide for treating prostate cancer08/09/2021 12:20:00
NICE has today (8 September 2021) published final draft guidance which now recommends apalutamide (also called Erleada and made by Janssen) plus androgen deprivation therapy for treating prostate cancer in adults
Sharing evidence with NICE is part of a broader approach to help Cochrane to identify priority reviews02/09/2021 11:15:00
Toby Lasserson, deputy editor in chief at Cochrane, writes about a new collaborative agreement with NICE, how it will work and what it means for the health service.
NICE approves ground-breaking cholesterol-lowering drug inclisiran01/09/2021 13:05:00
NICE has today (1 September 2021) issued draft final guidance recommending the novel anti-cholesterol drug inclisiran (Leqvio and made by Novartis) for people with primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke
NICE and Cochrane sign collaborative agreement to deliver ‘living’ guideline recommendations01/09/2021 12:05:00
NICE and Cochrane have today (01st September 2021) signed a collaborative agreement which will help to deliver ‘living’ recommendations across the NICE guideline portfolio.
NICE announces next steps for ME/CFS guideline31/08/2021 09:15:00
NICE recognises the importance to patients of the updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) and is keen to move forwards as quickly as possible.